Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
9
×
life sciences
9
×
national blog main
biotech
new york blog main
startups
boston blog main
san diego blog main
boston top stories
clinical trials
national top stories
san diego top stories
fda
medical device
new york top stories
san diego
san francisco blog main
seattle blog main
amgen
bayer
boston
cancer
cancer diagnostics
investing
ipo
medtech
merck
novartis
raleigh-durham blog main
san francisco top stories
seattle top stories
the medicines company
vc
wisconsin blog main
wisconsin top stories
10x genomics
480 biomedical
abbvie
achaogen
acquisition
What
company
9
×
deal
drug
medicines
bacteria
based
biology
developing
ipo
medical
new
public
raises
san
synthetic
technology
tests
that’s
therapeutics
acquire
acquisitions
add
adding
advance
agreed
aims
albert
biggest
billion
bio
biopharma
biotech
bioworks
bourla
brings
business
called
carlsmed
cash
ceo
Language
unset
unknown
Current search:
company
×
deals
×
" life sciences "
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Spine-Surgery Medtech Startup Carlsmed Merges With Imaging Company
@xconomy.com
4 years ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D
@xconomy.com
5 years ago
Shine Raises $30M, Could Add $150M More After Inking Deerfield Deal
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections